Maze Therapeutics, Inc.
MAZE
$25.56
-$0.87-3.29%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -122.54M | -131.12M | -126.13M | -120.80M | 51.94M |
| Total Depreciation and Amortization | 2.16M | 2.40M | 2.61M | 2.83M | 3.03M |
| Total Amortization of Deferred Charges | 371.00K | -- | -- | -- | -- |
| Total Other Non-Cash Items | 23.00M | 19.05M | 17.79M | 19.41M | 18.10M |
| Change in Net Operating Assets | -24.52M | -2.27M | -931.00K | -6.66M | -3.20M |
| Cash from Operations | -121.54M | -111.94M | -106.66M | -105.23M | 69.88M |
| Capital Expenditure | -588.00K | -794.00K | -1.37M | -1.40M | -1.17M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -163.80M | -170.17M | -66.82M | -- | -- |
| Cash from Investing | -164.39M | -170.96M | -68.18M | -1.40M | -1.17M |
| Total Debt Issued | 39.40M | -- | 0.00 | 0.00 | 259.00K |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 152.04M | 275.84M | 272.31M | 128.78M | 128.25M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | 70.79M | 70.79M | 70.79M |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.12M | -500.00K | -1.09M | -3.47M | -3.65M |
| Cash from Financing | 190.32M | 275.34M | 342.01M | 196.10M | 195.64M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -95.61M | -7.57M | 167.17M | 89.48M | 264.35M |